OBJECTIVE: To clarify the mechanism of thrombin receptor mediated signal transduction and the induction of cytokines by thrombin stimulation in rheumatoid synovial fibroblasts. METHODS: Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin. To assess the mechanism of thrombin receptor mediated signal transduction in the rheumatoid synovial fibroblasts, electrophoretic mobility gel shift assay (EMSA), immunoglobulin kappa-chloramphenicol acetyltransferase (CAT) assay, and immunostaining for NF-kappa B subunit molecule was performed. RESULTS: Thrombin stimulation activated the inducible transcription factor NF-kappa B, and then induced subsequent expressions of interleukin 6 (IL6) and granulocyte colony stimulating factor (G-CSF) in the cells. CONCLUSION: Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation.
OBJECTIVE: To clarify the mechanism of thrombin receptor mediated signal transduction and the induction of cytokines by thrombin stimulation in rheumatoid synovial fibroblasts. METHODS: Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin. To assess the mechanism of thrombin receptor mediated signal transduction in the rheumatoid synovial fibroblasts, electrophoretic mobility gel shift assay (EMSA), immunoglobulin kappa-chloramphenicol acetyltransferase (CAT) assay, and immunostaining for NF-kappa B subunit molecule was performed. RESULTS:Thrombin stimulation activated the inducible transcription factor NF-kappa B, and then induced subsequent expressions of interleukin 6 (IL6) and granulocyte colony stimulating factor (G-CSF) in the cells. CONCLUSION:Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation.
Authors: L R Zacharski; F E Brown; V A Memoli; W Kisiel; B J Kudryk; S M Rousseau; J A Hunt; C Dunwiddie; E M Nutt Journal: Clin Immunol Immunopathol Date: 1992-05
Authors: T Nakajima; H Aono; T Hasunuma; K Yamamoto; I Maruyama; T Nosaka; M Hatanaka; K Nishioka Journal: J Clin Invest Date: 1993-07 Impact factor: 14.808
Authors: J A Hamilton; T Leizer; D S Piccoli; K M Royston; D M Butler; M Croatto Journal: Biochem Biophys Res Commun Date: 1991-10-31 Impact factor: 3.575
Authors: T Nakajima; I Kitajima; H Shin; I Takasaki; K Shigeta; K Abeyama; Y Yamashita; T Tokioka; Y Soejima; I Maruyama Journal: Biochem Biophys Res Commun Date: 1994-10-28 Impact factor: 3.575
Authors: O Sánchez-Pernaute; R Largo; E Calvo; M A Alvarez-Soria; J Egido; G Herrero-Beaumont Journal: Ann Rheum Dis Date: 2003-12 Impact factor: 19.103
Authors: O Sánchez-Pernaute; J Esparza-Gordillo; R Largo; E Calvo; M A Alvarez-Soria; M E Marcos; G Herrero-Beaumont; S R de Córdoba Journal: Ann Rheum Dis Date: 2006-05-05 Impact factor: 19.103
Authors: Akanksha Gupta; Bruce Gerlitz; Mark A Richardson; Christopher Bull; David T Berg; Samreen Syed; Elizabeth J Galbreath; Barbara A Swanson; Bryan E Jones; Brian W Grinnell Journal: J Am Soc Nephrol Date: 2008-12-17 Impact factor: 10.121